Cipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...

Cipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...

"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...

The move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...

Drug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, wh...

Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...

Torrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...

Cipla has been closely associated with India's struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big...

Dr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...

Kunal Bothra recommended to keep stop loss at Rs 454.

A difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.

Consolidated sales stood at Rs 3,500 crore, compared with Rs 3,760 crore in the year-ago quarter. ET Now poll had estimated sales of Rs 8,3...

Vaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...

Samina Vaziralli, niece of Cipla Chairman YK Hamied, was appointed to the company's board on Thursday, thus inducting the next generation.

Even as Hamied prepares genext leaders for Cipla, it’s humanitarian face is out to shake up industry by delivering affordable biosimilar dr...

Drug firm Cipla today approved the retirement of its Executive Vice-Chairman, M K Hamied with effect from March 31, 2014.

ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.